Stock Report

Download full stock data and analysis for free Last Updated: 28-Aug-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Shasun Pharma Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: SHASUNPHAR | BSE: 524552

₹428.55

up-down-arrow ₹21.95 (5.40%)

As on 17-Nov-2015IST

Market cap

info icon

₹2,884 Cr

Revenue (TTM)

info icon

₹1,074 Cr

P/E Ratio

info icon

63.8

P/B Ratio

info icon

6

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 4.21 -3.99 0.84 7.28 10.92
EBIT 18.95 6.31 20.98 -4.00 64.73
Net Profit 67.81 0.43 22.45 -38.11 44.63
EPS 67.81 -10.18 -25.95 -39.95 38.34
Book Value -- -- 11.90 14.54 19.58
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-15Mar-14
EBIT-Margin info 6.205.477.565.544.11
Net Margin info 3.604.254.111.792.45
Return on equity info 11.0626.5810.337.2510.62
Return on Capital info 9.4413.47--8.828.23
Return on Assets info 3.345.473.241.712.58
Debt to Equity (x) info ----0.342.072.30

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-15
Mar-14
Mar-13
Mar-12
Shasun Pharma
--
--
--
10.79
9.06
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

--

--

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-15
Mar-14
Mar-13
Mar-12
Shasun Pharma
--
--
10.33
11.71
11.79
Peer Median
10.86
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

--

--

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-15
Mar-14
Mar-13
Mar-12
Shasun Pharma
--
--
3.24
3.36
3.43
Peer Median
6.74
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

10.27

Lower than Peers by 2.42

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-15
Mar-14
Mar-13
Mar-12
Shasun Pharma
10.27
12.88
7.56
7.81
6.12
Peer Median
12.69
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

9.35

Higher than Peers by 0.49

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-15
Mar-14
Mar-13
Mar-12
Shasun Pharma
9.35
10.15
4.11
3.79
3.72
Peer Median
8.86
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-15
Mar-14
Mar-13
Mar-12
Shasun Pharma
--
--
--
7.02
7.60
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

--

--

Year on year growth in net sales

Company Name
TTM
Mar-15
Mar-14
Mar-13
Mar-12
Shasun Pharma
--
--
0.84
15.37
19.41
Peer Median
8.14
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-9.61

Lower than Peers by 26.86

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-15
Mar-14
Mar-13
Mar-12
Shasun Pharma
-9.61
9.33
20.98
47.21
56.92
Peer Median
17.24
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

--

--

Year on year growth in profit after tax

Company Name
TTM
Mar-15
Mar-14
Mar-13
Mar-12
Shasun Pharma
--
--
22.45
17.38
34.05
Peer Median
16.85
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

--

--

Year on year growth in earnings per share

Company Name
TTM
Mar-15
Mar-14
Mar-13
Mar-12
Shasun Pharma
--
--
12.99
10.55
34.05
Peer Median
10.60
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-15
Mar-14
Mar-13
Mar-12
Shasun Pharma
--
--
--
25.14
10.43
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Mar-15
Mar-14
Mar-13
Mar-12
Shasun Pharma
--
--
0.34
1.49
1.70
Peer Median
0.04
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-15
Mar-14
Mar-13
Mar-12
Shasun Pharma
--
--
0.95
0.86
0.98
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

--

--

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-15
Mar-14
Mar-13
Mar-12
Shasun Pharma
--
--
0.85
0.96
0.90
Peer Median
1.72
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

--

--

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-15
Mar-14
Mar-13
Mar-12
Shasun Pharma
--
--
0.57
0.67
0.61
Peer Median
1.17
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-15
Mar-14
Mar-13
Mar-12
Shasun Pharma
--
--
2.13
1.85
1.67
Peer Median
7.86
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

29.46

Higher than Peers by 3.67

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-15
Mar-14
Mar-13
Mar-12
Shasun Pharma
29.46
25.71
31.37
27.48
30.50
Peer Median
25.79
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

--

--

Sales / Average Total Assets

Company Name
TTM
Mar-15
Mar-14
Mar-13
Mar-12
Shasun Pharma
--
--
0.78
0.91
0.94
Peer Median
0.67
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-15
Mar-14
Mar-13
Mar-12
Shasun Pharma
--
--
--
95.31
95.57
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-15
Mar-14
Mar-13
Mar-12
Shasun Pharma
--
--
--
64.80
62.20
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-15
Mar-14
Mar-13
Mar-12
Shasun Pharma
--
--
--
93.19
86.98
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-15
Mar-14
Mar-13
Mar-12
Shasun Pharma
--
--
--
66.92
70.79
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-15
Mar-14
Mar-13
Mar-12
Shasun Pharma
--
--
63.83
53.96
11.37
Peer Median
39.76
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

--

--

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-15
Mar-14
Mar-13
Mar-12
Shasun Pharma
--
--
5.99
5.68
1.28
Peer Median
4.21
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-15
Mar-14
Mar-13
Mar-12
Shasun Pharma
--
--
--
--
1.41
Peer Median
0.10
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

--

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-15
Mar-14
Mar-13
Mar-12
Shasun Pharma
--
--
23.71
20.85
8.58
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

--

--

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-15
Mar-14
Mar-13
Mar-12
Shasun Pharma
--
--
2,884
2,231
401
Peer Median
7,384
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...